Mildronate, meldonium history
1970 Mildronate is developed at the head of professor Ivars Kalvins by the group of scientists at the Latvian Institute of Organic Synthesis.
1976 First licence for registering and Certification of the Soviet Union writers.
1984 Allowed for use in medication.
1988–2007 Registered in Armenia, Albania, Azerbaijan, Belarus, Georgia, Kazakhstan, Kosovo, Kyrgyzstan, Latvia, Lithuania, Moldova, Mongolia, Russia, Tajikistan, Turkmenistan, Ukraine and Uzbekistan.
2002–2005 Recognized as the greatest export merchandise of Latvia.
2005 – 2008 Is recognized as the greatest prescription drug of foreign production at Ukraine.
2006– 2008 Is ranked among products in Belarus.
2008 Mildronate is a part of the Top-20 products in the commercial section of the pharmaceutical marketplace of Russia.
2010–2014 Registration in Latvia, Ukraine, Uzbekistan, Azerbaijan, Tajikistan, Turkmenistan, Kazakhstan, Kyrgyzstan and Armenia.
2011 “The Cardiological medicament of the year” at Ukraine.
2015 – Meldonuim are Latvian-made pharmaceutical TOP seller in Latvia.
2016 – Mildronate develops enormous marketing when it turned out that, despite the inclusion in the WADA (World Anti-Doping Agency) list of prohibited materials for athletes from 1 January.